| Lab | Valuation | Founded | Space | HQ | Founders | More | Jobs |
|---|---|---|---|---|---|---|---|
| Living Models | — | 2025 | Bio / AI drug discovery | Paris / Berkeley | Cyril Veran, Leonard Strouk, Bertrand Gakiere | Details | Apply |
| Phylo | — | 2025 | Bio / AI drug discovery | South San Francisco | Kexin Huang, Yuanhao Qu, Jure Leskovec, Le Cong | Details | Apply |
| Helical | — | 2024 | Bio / AI drug discovery | Luxembourg | Rick Schneider, Maxime Allard, Mathieu Klop | Details | — |
| Converge Bio | — | 2023 | Bio / AI drug discovery | Boston / Tel Aviv | Dov Gertz | Details | — |
| Reliant AI | — | 2023 | Bio / AI drug discovery | Berlin / Montreal | Karl Moritz Hermann, Marc Bellemare, Richard Schlegel | Details | — |
| Terray Therapeutics | — | 2022 | Bio / AI drug discovery | Monrovia, CA | Jacob Berlin, Eli Berlin | Details | Apply |
| Enveda | — | 2019 | Bio / AI drug discovery | Boulder | Viswa Colluru | Details | Apply |
| Relation Therapeutics | — | 2019 | Bio / AI drug discovery | London | Charles Roberts, Benjamin Swerner, Jake Taylor-King | Details | — |
| Insilico Medicine | — | 2014 | Bio / AI drug discovery | Boston / Hong Kong | Alex Zhavoronkov | Details | Apply |
✓ confirmed valuation * rumored or estimated ~ approximate > lower bound < upper bound (mkt cap) public market cap (acq.) acquisition price